REGENERON PHARMACEUTICALS, INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31)
REGENERON PHARMACEUTICALS, INC. (REGN) had Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) of $1.79 million as of 2012-06-30, per its 10-Q filed 2012-07-25.
Discontinued › Notes › Investments
us-gaap:AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses1 · last filed 2012-07-25
- 2012-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) $1.79M.
- 2012-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) $683.00K.
- 2011-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) $1.26M.
- 2011-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) $1.18M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Losses (Deprecated 2012-01-31) |
|---|---|
| 2012-06-30 | $1.79M 10-Q · filed 2012-07-25 |
| 2012-03-31 | $683.00K 10-Q · filed 2012-04-26 |
| 2011-12-31 | $1.26M 10-Q · filed 2012-07-25 |
| 2011-09-30 | $1.18M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $167.00K 10-Q · filed 2011-07-28 |
| 2010-12-31 | $2.37M 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |